Multiple system atrophy, or MSA, is a rare neurodegenerative disorder with symptoms akin to ALS or Parkinson’s disease in the ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Miplyffa (arimoclomol), an oral medication for Neimann-Pick disease, type C (NPC). Miplyffa, in combination with Johnson & ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

For Zevra Therapeutics and its rare neurodegenerative disease med arimoclomol, the second time’s the charm. | The ...

McEwan and James have now taken advantage of TRIM21’s cluster activation by turning it against another protein with a ...

Neurodegenerative disorders, affecting millions of individuals in the United States, create a profound societal and economic ...

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical ...

Study connects the swip-10 gene in roundworms to copper metabolism and neurodegeneration. Loss of swip-10 impairs copper ...

ABOVE: Protein misfolding plays an important role in many neurodegenerative disorders. © istock.com, Eoneren. W hen Julie ...

Binghamton University Assistant Professor Jungwook "Jay" Paek is an electrical engineer - so how did he end up researching ...

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.